Primary coronary microvascular dysfunction: Clinical presentation, pathophysiology, and management

Circulation

Volumn 121, Issue 21, 2010, Pages 2317-2325

  Lanza, Gaetano Antonio ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Angina; Ischemia; Microcirculation; Syndrome X

Indexed keywords

ANGINA PECTORIS; CLINICAL FEATURE; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DIABETES MELLITUS; EPICARDIUM; HEART BLOOD VESSEL; HEART CONTRACTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERLIPIDEMIA; MICROCIRCULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SMOKING; SYNDROME X;

ADRENERGIC BETA-ANTAGONISTS; CALCIUM CHANNEL BLOCKERS; CARDIOMYOPATHIES; CORONARY DISEASE; ELECTROCARDIOGRAPHY; HUMANS; MICROVASCULAR ANGINA; MICROVESSELS; MYOCARDIAL ISCHEMIA;

EID: 77953218652     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.900191     Document Type: Review

References (62)

1. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356:830-840.
2. Cannon RO, Epstein SE. "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol. 1988;61: 1338-1343
3. Lanza GA. Cardiac syndrome X: a critical overview and future perspectives. Heart. 2007;93:159-166.
4. Cannon RO III, Camici PG, Epstein SE. The pathophysiologic dilemma of angina-like chest pain despite normal coronary angiograms. Circulation. 1992;85:883-892.
5. Larkin SW, Clarke JG, Keogh BE, Araujo L, Rhodes C, Davies GJ, Taylor KM, Maseri A. Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. Am J Cardiol. 1989;64: 956-958.
6. Nihoyannopoulos P, Kaski JC, Crake T, Maseri A. Absence of myo-cardial dysfunction during stress in patients with syndrome X. J Am Coll Cardiol. 1991;18:1463-1470.
7. Panza JA, Laurienzo JM, Curiel RV, Unger EF, Quyyumi AA, Dilsizian V, Cannon III R.O. Investigation of the mechanism of chest pain in patients with angiographically normal coronary arteries using transesoph-ageal dobutamine stress echocardiography. J Am Coll Cardiol. 1997;29: 293-301.
8. Camici PG, Marraccini P, Lorenzoni R, Buzzigoli G, Pecori N, Peris-sinotto A, Ferrannini E, L'Abbate A, Marzilli M. Coronary hemodynam-ics and myocardial metabolism in patients with syndrome X: response to pacing stress. J Am Coll Cardiol. 1991;17:1461-1470.
9. Maseri A, Crea F, Kaski JC, Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol. 1991;17:499-506.
10. Opherk D, Zebe H, Weihe E, Mall G, Durr C, Gravert B, Mehmel HC, Schwarz F, Kubler W. Reduced coronary dilator capacity and ultra-structural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms. Circulation. 1981;63:817-825.
11. Richardson PJ, Livesley B, Oram S, Olsen EG, Armstrong P. Angina pectoris with normal coronary arteries: transvenous myocardial biopsy in diagnosis. Lancet. 1974;2:677-680.
12. Motz W, Vogt M, Rabenau O, Scheler S, Luckhoff A, Strauer BE. Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms. Am J Cardiol. 1991;68:996-1003.
13. Chauhan A, Mullins PA, Taylor M, Petch MC, Schofield PM. Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms. Eur Heart J. 1997;18:60-68.
14. Bøttcher M, Bøtker HE, Sonne H, Nielsen TT, Czernin J. Endothelium-dependent and independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X. Circulation. 1999; 99:1795-1801.
15. Huang PH, Chen YH, Chen YL, Wu TC, Chen JW, Lin SJ. Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart. 2007;93:1064-1070.
16. Desideri G, Gaspardone A, Gentile M, Santucci A, Gioffrè PA, Ferri C. Endothelial activation in patients with cardiac syndrome X. Circulation. 2000;102:2359-2364.
17. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, Pennell DJ. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002;346:1948-1953.
18. Chauhan A, Mullins PA, Taylor G, Petch MC, Schofield PM. Effect of hyperventilation and mental stress on coronary blood flow in syndrome X. Br Heart J. 1993;69:516-524. (Pubitemid 23212782)
19. Bortone AS, Hess OM, Eberli FR, Nonogi H, Marolf AP, Grimm J, Krayenbuehl HP. Abnormal coronary vasomotion during exercise in patients with normal coronary arteries and reduced coronary flow reserve. Circulation. 1989;79:516-527.
20. Lanza GA, Lüscher TF, Pasceri V, Shaw SG, Buffon A, Montenero AS, Crea F, Maseri A. Effects of atrial pacing on arterial and coronary sinus endothelin-1 levels in syndrome X. Am J Cardiol. 1999;84:1187-1191.
21. Fragasso G, Chierchia SL, Arioli F, Carandente O, Gerosa S, Carlino M, Palloshi A, Gianolli L, Calori G, Fazio F, Margonato A. Coronary slow-flow causing transient myocardial hypoperfusion in patients with cardiac syndrome X: long-term clinical and functional prognosis. Int J Cardiol. 2009;137:137-144.
22. Greenberg MVA, Grose RM, Neuburger N, Silverman R, Strain JE, Cohen MV. Impaired coronary vasodilator responsiveness as a cause of lactate production during pacing-induced ischemia in patients with angina pectoris and normal coronary arteries. J Am Coll Cardiol. 1987;9: 743-751.
23. Crake T, Canepa-Anson R, Shapiro L, Poole-Wilson PA. Continuous recording of coronary sinus oxygen saturation during atrial pacing in patients with coronary artery disease or with syndrome X. Br Heart J. 1988;59:31-38.
24. Buffon A, Rigattieri S, Santini SA, Ramazzotti V, Crea F, Giardina B, Maseri A. Myocardial ischemia-reperfusion damage after pacing-induced tachycardia in patients with cardiac syndrome X. Am J Physiol. 2000; 279:H2627-H2633.
25. Buchthal SD, den Hollander JA, Merz CNB, Rogers WJ, Pepine CJ, Reichek N, Sharaf BL, Reis S, Kelsey SF, Pohost GM. Abnormal myo-cardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med. 2000;342:829-835.
26. Wessel TR, Arant CB, McGorray SP, Sharaf BL, Reis SE, Kerensky RA, von Mering GO, Smith KM, Pauly DF, Handberg EM, Mankad S, Olson MB, Johnson BD, Merz CN, Sopko G, Pepine CJ; NHLBI Women's Ischemia Syndrome Evaluation (WISE). Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE). Clin Cardiol. 2007;30:69-74.
27. Lanza GA, Giordano AG, Pristipino C, Calcagni ML, Meduri G, Trani C, Franceschini R, Crea F, Troncone L, Maseri A. Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [123I]meta-iodo-benzylguanidine myocardial scintigraphy. Circulation. 1997;96:821-826.
28. Bøtker HE, Moller N, Ovesen P, Mengel A, Schmitz O, Orskov H, Bagger JP. Insulin resistance in microvascular angina (syndrome X). Lancet. 1993;342:136-140.
29. Kaski JC. Cardiac syndrome X in women: the role of oestrogen deficiency. Heart. 2006;92(suppl 3):5-9.
30. Koren W, Koldanov R, Peleg E, Rabinowitz B, Rosenthal T. Enhanced red cell sodium-hydrogen exchange in microvascular angina. Eur Heart J. 1997;18:1296-1299.
31. Lanza GA, Sestito A, Cammarota G, Grillo RL, Vecile E, Cianci R, Speziale D, Dobrina A, Maseri A, Crea F. Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X. Am J Cardiol. 2004;94:40-44.
32. Cosin-Sales J, Pizzi C, Brown S, Kaski JC. C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms. J Am Coll Cardiol. 2003;41:1468-1474.
33. Kaski JC, Rosano GMC, Collins P, Nihoyannopoulos P, Maseri A, Poole-Wilson PA. Cardiac syndrome X: clinical characteristics and left ventricular function: long-term follow-up study. J Am Coll Cardiol. 1995;25:807-814.
34. Lamendola P, Lanza GA, Spinelli A, Sgueglia GA, Di Monaco A, Barone L, Sestito A, Crea F. Long-term prognosis of patients with cardiac syndrome X. Int J Cardiol. 2010;140:197-199.
35. Lanza GA, Manzoli A, Bia E, Crea F, Maseri A. Acute effects of nitrates on exercise testing in patients with syndrome X. Circulation. 1994;90: 2695-2700.
36. Infusino F, Lanza GA, Sestito A, Sgueglia GA, Crea F, Maseri A. Combination of variant and microvascular angina. Clin Cardiol. 2009; 32:E40-E45.
37. Lanza GA, Buffon A, Sestito A, Natale L, Sgueglia GA, Galiuto L, Infusino F, Mariani L, Centola A, Crea F. Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. J Am Coll Cardiol. 2008;51:466-472.
38. Galiuto L, Sestito A, Barchetta S, Sgueglia GA, Infusino F, La Rosa C, Lanza G, Crea F. Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X. Am J Cardiol. 2007;99:1378-1383.
39. Cannon RO III, Quyyumi AA, Schenke WH, Fananapazir L, Tucker EE, Gaughan AM, Gracely RH, Cattau EL Jr, Epstein SE. Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries. J Am Coll Cardiol. 1990;16:1359-1366.
40. Lanza GA, Colonna G, Pasceri V, Maseri A. Atenolol versus amlodipine versus isosorbide5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol. 1999;84:854-856.
41. Kaski JC, Rosano G, Gavrielides S, Chen L. Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina. J Am Coll Cardiol. 1994;23:652-657.
42. Botker HE, Sonne HS, Schmitz O, Nielsen TT. Effects of doxazosin on exercise-induced angina pectoris, ST-segment depression, and insulin sensitivity in patients with syndrome X. Am J Cardiol. 1998;82: 1352-1356.
43. Fabian E, Varga A, Picano E, Vajo Z, Ronaszeki A, Csanady M. Effect of simvastatin on endothelial function in cardiac syndrome X patients. Am J Cardiol. 2004;94:652-655.
44. Emdin M, Picano E, Lattanzi F, L'Abbatte A. Improved exercise capacity with acute aminophylline administration in patients with syndrome X. J Am Coll Cardiol. 1989;14:1450-1453. (Pubitemid 19279042)
45. Cannon RO, Quyyumi AA, Mincemoyer R, Stine AM, Gracely RH, Smith WB, Geraci MF, Black BC, Uhde TW, Waclawiw MVA, Maher K, Benjamin SB. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 1994;330:1411-1417.
46. Sgueglia GA, Sestito A, Spinelli A, Cioni B, Infusino F, Papacci F, Bellocci F, Meglio M, Crea F, Lanza GA. Long-term follow-up of patients with cardiac syndrome X treated by spinal cord stimulation. Heart. 2007;93:591-597.
47. Bugiardini R, Manfrini O, De Ferrari GM. Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch Intern Med. 2006;166:1391-1395.
48. Chauhan A, Mullins PA, Thuraisingham SI, Petch MC, Schofield PM. Clinical presentation and functional prognosis in syndrome X. Br Heart J. 1993;70:346-351.
49. Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon: a new coronary microvascular disorder. Cardiology. 2002;97: 197-202.
50. Beltrame JF, Limaye SB, Wuttke RD, Horowitz JD. Coronary hemody-namic and metabolic studies of the coronary slow flow phenomenon. Am Heart J. 2003;146:84-90.
51. Mangieri E, Macchiarelli G, Ciavolella M, Barillà F, Avella A, Martinotti A, Dell'Italia LJ, Scibilia G, Motta P, Campa PP. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn. 1996;37:375-381.
52. Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U. Coronary artery spasm as a frequent cause of acute coronary syndrome: the CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. J Am Coll Cardiol. 2008;52:523-527.
53. Beltrame JF, Turner SP, Leslie SL, Solomon P, Freedman SB, Horowitz JD. The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon. J Am Coll Cardiol. 2004;44:57-62.
54. Mohri M, Koyanagi M, Egashira K, Tagawa H, Ichiki T, Shimokawa H, Takeshita A. Angina pectoris caused by coronary microvascular spasm. Lancet. 1998;351:1165-1169.
55. Mohri M, Shimokawa H, Hirakawa Y, Masumoto A, Takeshita A. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. J Am Coll Cardiol. 2003;41:15-19.
56. Bybee KA, Prasad A. Stress-related cardiomyopathy syndromes. Circulation. 2008;118:397-409.
57. Wittstein IS, Thiemann DR, Lima JAC, Baughman KL, Shulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC. Neuro-humoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352:539-548.
58. Baumgart D, Heusch G. Neuronal control of coronary blood flow. Basic Res Cardiol. 1995;90:142-159.
59. Kurisu S, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, Umemura T, Nakamura S, Yoshida M, Sato H. Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo-like left ventricular dysfunction. J Am Coll Cardiol. 2003;41:743-748.
60. Kume T, Akasaka T, Kawamoto T, Watanabe N, Yoshitani H, Akiyama M, Koyama Y, Neishi Y, Tsukiji M, Yoshida K. Relationship between coronary flow reserve and recovery of regional left ventricular dysfunction in patients with tako-tsubo-like transient left ventricular dysfunction. J Cardiol. 2004;43:123-129.
61. Meimoun P, Malaquin D, Sayah S, Benali T, Luycx-Bore A, Levy F, Zemir H, Tribouilloy C. The coronary flow reserve is transiently impaired in tako-tsubo cardiomyopathy: a prospective study using serial Doppler transthoracic echocardiography. J Am Soc Echocardiogr. 2008;21:72-77.
62. Lanza GA, Sestito A, Iacovella S, Morlacchi L, Romagnoli E, Schiavoni G, Crea F, Maseri A, Andreotti F. Relation between platelet response to exercise and coronary angiographic findings in patients with effort angina. Circulation. 2003;107:1378-1382.